Cumberland Pharmaceuticals Inc. (CPIX) stock surged +35.11%, trading at $5.08 on NASDAQ, up from the previous close of $3.76. The stock opened at $3.84, fluctuating between $3.84 and $6.43 in the recent session.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate that is in Phase II clinical trial for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Employees | 91 |
Beta | 0.22 |
Sales or Revenue | $39.55M |
5Y Sales Change% | 0.057% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) stock price is $5.08 in the last trading session. During the trading session, CPIX stock reached the peak price of $6.43 while $3.84 was the lowest point it dropped to. The percentage change in CPIX stock occurred in the recent session was 35.11% while the dollar amount for the price change in CPIX stock was $1.32.
The NASDAQ listed CPIX is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Cumberland Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Cindy B. Patton
Senior Director of Field Marketing
Ms. Jean W. Marstiller
Senior Vice President of Admin. Services & Corporation Sec.
Mr. A. J. Kazimi MBA
Founder, Chairman, Pres & Chief Executive Officer
Mr. John Michael Hamm
Chief Financial Officer
Ms. Erin Smith Gull
Senior Corporation Relations Associate
Mr. Todd M. Anthony
Vice President of Organizational Devel.
Mr. James Lowrance Herman
Executive Vice President of National Accounts & Chief Compliance Officer
Mr. Chris T. Bitterman
Vice President of Sales & Marketing
CPIX's closing price is 388.46% higher than its 52-week low of $1.04 where as its distance from 52-week high of $6.43 is -21%.
Number of CPIX employees currently stands at 91.
Official Website of CPIX is: https://www.cumberlandpharma.com
CPIX could be contacted at phone 615 255 0068 and can also be accessed through its website. CPIX operates from 2525 West End Avenue, Nashville, TN 37203, United States.
CPIX stock volume for the day was 59.43M shares. The average number of CPIX shares traded daily for last 3 months was 2.07M.
The market value of CPIX currently stands at $71.33M with its latest stock price at $5.08 and 14.04M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com